Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02585206 · ClinicalTrials.gov registry record · NA
Optimizing Text Messaging to Improve Adherence to Web-Based Cessation Treatment
A NA study, sponsored by Truth Initiative.
- Completed
- Registry status
- NA
- Development phase
- 1,485
- Enrollment target
NCT02585206: Completed NA study, sponsored by Truth Initiative.
NCT02585206 is a NA study that has completed, run by Truth Initiative. The registered enrollment target is 1,485 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02585206, a NA study, has completed, sponsored by Truth Initiative.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,485 participants
- Enrollment target
Study Summary
This study is comprised of 2 phases to study the impact of a text message system on overall adherence to a web-based smoking cessation program. Phase I uses a full factorial design to identify the most optimal text message intervention to maximize adherence to the BecomeAnEX.org smoking cessation program. Phase II is a randomized controlled trial that compares regular BecomeAnEX users to those who will receive the optimized text message intervention (from Phase I) in conjunction with BecomeAnEX for impact on long-term abstinence.
Primary Outcome
The investigators will create a composite metric of adherence for each Phase I participant using a weighted sum of their total number of number of visits, as well as of their page views, time on site, and use of the 6 interactive components of the site per visit during 3 months post-enrollment.
Interventions
- BEHAVIORAL Personalization
- BEHAVIORAL Integration
- BEHAVIORAL Dynamic Tailoring
- BEHAVIORAL Message Intensity
- BEHAVIORAL Optimal-Adherence Text
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,485 participants |
| Start Date | 2018-03-29 |
| Est. Completion | 2020-07-10 |
| Phase | NA |
What the finished NCT02585206 record still lists
NCT02585206 is an interventional study that assigns participants to a tested intervention. Its 1,485 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 5 interventions - of which Personalization is the first listed.
NCT02585206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02585206 about?
NCT02585206 is a clinical study titled "Optimizing Text Messaging to Improve Adherence to Web-Based Cessation Treatment". This study is comprised of 2 phases to study the impact of a text message system on overall adherence to a web-based smoking cessation program. Phase I uses a full factorial design to identify the most optimal text message intervention to maximize adherence to the BecomeAnEX.org smoking cessation pr...
What is the current status of trial NCT02585206?
This trial is currently completed. It is a NA study. The enrollment target is 1,485 participants. The study started on 2018-03-29. Estimated completion is 2020-07-10.
What interventions are being tested in trial NCT02585206?
The interventions under investigation include: Personalization (BEHAVIORAL), Integration (BEHAVIORAL), Dynamic Tailoring (BEHAVIORAL), Message Intensity (BEHAVIORAL), Optimal-Adherence Text (BEHAVIORAL).
Who is sponsoring clinical trial NCT02585206?
This trial is sponsored by Truth Initiative, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02585206's enrollment target sits among peer trials
1,485 68th of 2000 higher than 1,933 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI